A multi-team system implementation strategy to improve buprenorphine adherence for patients who initiate treatment in the emergency department
多团队系统实施策略,以提高在急诊科开始治疗的患者的丁丙诺啡依从性
基本信息
- 批准号:10740793
- 负责人:
- 金额:$ 100.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AbstinenceAccident and Emergency departmentAddressAdministratorAdoptionAffectAlcoholsBuprenorphineCaliforniaCaringClinicalClinical TrialsComplexConsolidated Framework for Implementation ResearchDataData CollectionDrug AddictionDrug usageElementsEmergency CareEmergency department visitFrequenciesFundingGoalsHealth systemHospitalsHybridsIndividualInsuranceInterviewKnowledgeLeadershipLegal patentLow incomeMaintenanceMedicaidMissionModelingOutpatientsOverdose reductionPatient CarePatient-Focused OutcomesPatientsPeripheralPharmaceutical PreparationsPhasePrimary CareProfessional counselorProtocols documentationPublic HealthRandomizedScienceSiteSurveysSystemSystems TheoryTestingTreatment outcomeUnited States Agency for Healthcare Research and QualityUnited States National Institutes of HealthWorkaddictionbridge programbuprenorphine treatmentcandidate identificationcare coordinationcare fragmentationcare seekingcompliance behaviordesigneffective therapyeffectiveness measureeffectiveness outcomeeffectiveness/implementation studyimplementation measuresimplementation outcomesimplementation researchimplementation scienceimplementation strategyimplementation studyimprovedinnovationlensmembernovelopioid mortalityopioid overdoseopioid use disorderoverdose deathpatient populationpatient safetypost implementationprescription monitoring programprimary care clinicprimary care patientprimary care teamprimary care visitprogramsprospectiveretention rate
项目摘要
PROJECT SUMMARY/ABSTRACT
Drug overdose deaths continue to rise in the US due largely to opioid-related deaths, despite availability of
buprenorphine, a highly effective treatment for opioid use disorder (OUD). Starting buprenorphine for OUD in
emergency departments is an increasingly common practice across the US. A large clinical trial found that
emergency department-initiated buprenorphine plus referral to primary care for ongoing treatment significantly
increased buprenorphine treatment rates, but effects were not sustained past two months. Effective strategies
to help patients start, restart, and sustain buprenorphine treatment are urgently needed to reduce overdose
deaths. To increase buprenorphine treatment, California established CA Bridge, a state-funded program in
>200 hospitals that offers same-day buprenorphine initiation plus referral to primary care for patients with OUD
who seek care in emergency departments. However, suboptimal care coordination persists, especially for low-
income patients. This study’s overarching hypothesis is that an implementation strategy that encourages
coordination involving ongoing partnerships rather than one-time handoffs between emergency department
and primary care teams will improve buprenorphine treatment and retention rates for patients who start
buprenorphine in the emergency department. The objective is to refine an implementation strategy informed by
multiteam systems theory that is focused on improving OUD care coordination between emergency
department and primary care teams and then test this strategy in a hybrid type III effectiveness-implementation
study using a stepped wedge design randomized at the site level. The R61 phase will involve collecting and
analyzing data from two CA Bridge sites to identify core and peripheral elements of this implementation
strategy and develop an implementation strategy, a preliminary implementation blueprint, and data collection
protocols for the R33 phase. The stepped wedge study during the R33 phase will involve four CA Bridge sites.
Implementation outcomes will include between-team coordinating activities and care transitions. Effectiveness
outcomes will include rates of outpatient buprenorphine initiation (filling ≥1 outpatient prescription) and
sustained buprenorphine treatment 3, 6, and 12 months after patients leave the emergency department,
assessed with data from California’s prescription drug monitoring program. Factors associated with successful
implementation and sustainability will be identified through pre- and post-implementation interviews with
patients, staff, and managers at each emergency department and primary care clinic and through engagement
with relevant stakeholders, including patients, CA Bridge statewide leadership and prospective payers. Study
results will be used to develop an implementation blueprint that hospitals in California and across the US can
use to improve OUD treatment outcomes for patients who start buprenorphine in emergency departments. This
study will advance efforts to improve long-term buprenorphine treatment rates at scale for low-income and
other vulnerable patients who disproportionately seek OUD care in emergency departments.
项目摘要/摘要
药物过量死亡在美国继续增加,这在很大程度上是由于阿片类药物相关的死亡,目的地的可用性
丁丙诺啡是阿片类药物使用障碍(OUD)的高效治疗方法。启动丁丙诺啡的OUD
急诊部门是整个美国越来越普遍的做法。一项大型临床试验发现
急诊室发起的丁丙诺啡加上转介给初级保健,以进行正在进行的治疗
丁丙诺啡治疗率提高,但在过去两个月中的影响没有持续。有效的策略
为了帮助患者开始,重新启动和维持丁丙诺啡治疗以减少过量
死亡人数。为了增加丁丙诺啡治疗,加利福尼亚建立了CA Bridge,这是一项由国家资助的计划
> 200医院提供当天丁丙诺啡倡议,并为OUD患者转诊至初级保健
在急诊室寻求护理的人。但是,次优的护理协调持续存在,特别是对于低 -
收入患者。这项研究的总体假设是一种鼓励的实施策略
涉及持续合作伙伴关系而不是急诊室之间的交接的协调
初级保健团队将改善开始的患者的丁丙诺啡治疗和保留率
急诊室的丁丙诺啡。目的是完善由
多立场系统理论的重点是改善紧急情况之间的OUD护理协调
部门和初级保健团队,然后在混合III型实施中测试此策略
使用在现场级别随机进行阶梯楔形设计的研究。 R61阶段将涉及收集和
分析来自两个CA桥接站点的数据,以识别此实现的核心和外围元素
策略和开发实施策略,初步实施蓝图和数据收集
R33阶段的协议。 R33期间的坡度研究将涉及四个CA桥接位。
实施成果将包括团队之间的协调活动和护理过渡。效力
结果将包括门诊贝班确实载倡议(填充≥1个门诊处方)和
患者离开急诊科后,持续的丁丙诺啡治疗3、6和12个月,
通过加利福尼亚处方药监测计划的数据进行评估。与成功相关的因素
实施和可持续性将通过实施前后的访谈来确定
每个急诊科和初级保健诊所的患者,员工和经理以及通过参与
与包括患者在内的相关利益相关者,CA桥梁全州领导层和潜在付款人。学习
结果将用于开发加利福尼亚州和美国各地医院的实施蓝图
用于改善在急诊部门开始丁丙诺啡的患者的OUD治疗结果。这
研究将在低收入和
其他不成比例地在急诊室寻求OUD护理的弱势患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen G Henry其他文献
Stephen G Henry的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen G Henry', 18)}}的其他基金
Developing Patient-level Risk Prediction Models for Prescription Opioid Overdose
开发处方阿片类药物过量的患者级风险预测模型
- 批准号:
9982285 - 财政年份:2017
- 资助金额:
$ 100.52万 - 项目类别:
Developing Patient-level Risk Prediction Models for Prescription Opioid Overdose
开发处方阿片类药物过量的患者级风险预测模型
- 批准号:
9364793 - 财政年份:2017
- 资助金额:
$ 100.52万 - 项目类别:
A clinician training intervention to improve pain-related communication, pain management and opioid prescribing in primary care
临床医生培训干预,以改善初级保健中与疼痛相关的沟通、疼痛管理和阿片类药物处方
- 批准号:
9223594 - 财政年份:2017
- 资助金额:
$ 100.52万 - 项目类别:
Harnessing patient narratives to promote opioid tapering in primary care
利用患者的叙述来促进初级保健中阿片类药物的逐渐减少
- 批准号:
9304166 - 财政年份:2016
- 资助金额:
$ 100.52万 - 项目类别:
Harnessing patient narratives to promote opioid tapering in primary care
利用患者的叙述来促进初级保健中阿片类药物的逐渐减少
- 批准号:
9166045 - 财政年份:2016
- 资助金额:
$ 100.52万 - 项目类别:
相似海外基金
An Enzyme-Based Antidote for Acute Nicotine Toxicity
一种基于酶的急性尼古丁中毒解毒剂
- 批准号:
10790758 - 财政年份:2023
- 资助金额:
$ 100.52万 - 项目类别:
Transporting treatment effects from clinical trials to real-world populations with co-occurring opioid and stimulant use disorders
将临床试验的治疗效果转移到同时发生阿片类药物和兴奋剂使用障碍的现实人群中
- 批准号:
10526149 - 财政年份:2022
- 资助金额:
$ 100.52万 - 项目类别:
Ketamine for the treatment for alcohol use disorder in the emergency department: A pilot double-blind, placebo-controlled randomized clinical trial
氯胺酮在急诊科治疗酒精使用障碍:一项双盲、安慰剂对照随机临床试验
- 批准号:
10593244 - 财政年份:2022
- 资助金额:
$ 100.52万 - 项目类别:
Effect of methadone on the developmental properties of human brain organoids
美沙酮对人脑类器官发育特性的影响
- 批准号:
10442944 - 财政年份:2022
- 资助金额:
$ 100.52万 - 项目类别:
Ketamine for the treatment for alcohol use disorder in the emergency department: A pilot double-blind, placebo-controlled randomized clinical trial
氯胺酮在急诊科治疗酒精使用障碍:一项试点双盲、安慰剂对照随机临床试验
- 批准号:
10703512 - 财政年份:2022
- 资助金额:
$ 100.52万 - 项目类别: